Literature DB >> 30528350

Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype.

John Reiser1, Kavitha Sadashivaiah2, Aki Furusawa2, Arnob Banerjee2, Nevil Singh3.   

Abstract

CD8+ T cell differentiation is controlled by the transcription factors T-bet and Eomesodermin, in concert with the cytokines IL-2, IL-10 and IL-12. Among these pathways, the mechanisms by which T-box proteins and IL-10 interact to promote a memory T cell fate remain poorly understood. Here, we show that Eomes and IL-10 drive a central memory phenotype in murine CD8+ T cells. Eomes expression led to increased IL-10 expression by the effector CD8+ T cells themselves as well as an increase in the level of the lymph node homing selectin CD62L. Furthermore, exposure of effector CD8+ T cells to IL-10 maintained CD62L expression levels in culture. Thus, Eomes promotes a step-wise transition of effector T cells towards a memory phenotype, synergizing with IL-10 to enhance the expression of CD62L. The early augmentation of lymph node homing markers by Eomes may facilitate the retention of effector T cells in the relatively low inflammatory milieu of the secondary lymphoid organs that promotes central memory development.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD62L; Central-memory T cell; Effector T cell; Eomes; IL-10; T-bet

Mesh:

Substances:

Year:  2018        PMID: 30528350      PMCID: PMC6449173          DOI: 10.1016/j.cellimm.2018.11.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  73 in total

1.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

2.  Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.

Authors:  Tanja Kaartinen; Annu Luostarinen; Pilvi Maliniemi; Joni Keto; Mikko Arvas; Heini Belt; Jonna Koponen; Petri I Mäkinen; Angelica Loskog; Satu Mustjoki; Kimmo Porkka; Seppo Ylä-Herttuala; Matti Korhonen
Journal:  Cytotherapy       Date:  2017-06-20       Impact factor: 5.414

3.  IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment.

Authors:  Ellen M Palmer; Beth C Holbrook; Subhashini Arimilli; Griffith D Parks; Martha A Alexander-Miller
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

4.  IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.

Authors:  Mark P Rubinstein; Nicholas A Lind; Jared F Purton; Pauline Filippou; J Adam Best; Patrick A McGhee; Charles D Surh; Ananda W Goldrath
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

5.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

Review 6.  T-bet: a bridge between innate and adaptive immunity.

Authors:  Vanja Lazarevic; Laurie H Glimcher; Graham M Lord
Journal:  Nat Rev Immunol       Date:  2013-10-11       Impact factor: 53.106

7.  CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs.

Authors:  Jie Sun; Haley Dodd; Emily K Moser; Rahul Sharma; Thomas J Braciale
Journal:  Nat Immunol       Date:  2011-02-06       Impact factor: 25.606

8.  The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion.

Authors:  Catherine Haluszczak; Adovi D Akue; Sara E Hamilton; Lisa D S Johnson; Lindsey Pujanauski; Lenka Teodorovic; Stephen C Jameson; Ross M Kedl
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

9.  GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells.

Authors:  John Shoemaker; Margarida Saraiva; Anne O'Garra
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

10.  Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.

Authors:  Fernando Cruz-Guilloty; Matthew E Pipkin; Ivana M Djuretic; Ditsa Levanon; Joseph Lotem; Mathias G Lichtenheld; Yoram Groner; Anjana Rao
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  6 in total

Review 1.  Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back.

Authors:  Viviane Schmidt; Andrew E Hogan; Padraic G Fallon; Christian Schwartz
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

2.  Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.

Authors:  Kunal Dhume; Caroline M Finn; Priyadharshini Devarajan; Ayushi Singh; Joanne D Tejero; Emily Prokop; Tara M Strutt; Stewart Sell; Susan L Swain; Karl Kai McKinstry
Journal:  J Immunol       Date:  2022-03-25       Impact factor: 5.426

3.  EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia.

Authors:  Philipp M Roessner; Laura Llaó Cid; Ekaterina Lupar; Ana Izcue; Martina Seiffert; Tobias Roider; Marie Bordas; Christoph Schifflers; Lavinia Arseni; Ann-Christin Gaupel; Fabian Kilpert; Marit Krötschel; Sebastian J Arnold; Leopold Sellner; Dolors Colomer; Stephan Stilgenbauer; Sascha Dietrich; Peter Lichter
Journal:  Leukemia       Date:  2021-02-01       Impact factor: 11.528

4.  Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.

Authors:  Nianci Chen; Yingxi Xu; Junli Mou; Qing Rao; Haiyan Xing; Zheng Tian; Kejing Tang; Min Wang; Jiangxiang Wang
Journal:  Blood Cancer J       Date:  2021-08-14       Impact factor: 11.037

5.  Metabolic alterations impair differentiation and effector functions of CD8+ T cells.

Authors:  Antonio Bensussen; Maria Angelica Santana; Otoniel Rodríguez-Jorge
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

6.  Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice.

Authors:  Yuchao Chen; Yuhong Yan; Huazhen Liu; Feifei Qiu; Chun-Ling Liang; Qunfang Zhang; Run-Yue Huang; Ling Han; Chuanjian Lu; Zhenhua Dai
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.